(Ebook) Infectious Disease Surveillance, Second Edition by Nkuchia M. M'ikanatha, Ruth Lynfield, Chris A. Van Beneden, Henriette de Valk ISBN 9780470654675, 9781118543504, 0470654678, 1118543505

(Ebook) Infectious Disease Surveillance, Second Edition by Nkuchia M. M'ikanatha, Ruth Lynfield, Chris A. Van Beneden, Henriette de Valk ISBN 9780470654675, 9781118543504, 0470654678, 1118543505

Content: Chapter 1 Infectious disease surveillance: a cornerstone for prevention and control (pages 1–20): Nkuchia M. M'ikanatha, Ruth Lynfield, Kathleen G. Julian, Chris A. Van Beneden and Henriette de ValkChapter 2 Origins and progress in surveillance systems (pages 21–31): Stephen B. Thacker and Donna F. StroupChapter 3.1 Use of surveillance in disease eradication efforts: PART 1: Introduction to the concept and use of surveillance in the eradication of smallpox (pages 32–40): D.A. HendersonChapter 3.2 Use of surveillance in disease eradication efforts: PART 2: Lessons learned in Guinea worm disease (dracunculiasis) eradication (pages 41–53): Samuel Makoy, Steven R. Becknell, Alexander H. Jones, Gabriel Waat, Ernesto Ruiz?tiben and Donald R. HopkinsChapter 3.3 Use of surveillance in disease eradication efforts: PART 3: Surveillance for measles eradication in countries with limited resources (pages 54–61): Mark Grabowsky, Mac Otten and Balcha MasreshaChapter 4 Infectious disease surveillance and the International Health Regulations (pages 62–80): Bruce J. Plotkin and Maxwell C. HardimanChapter 5 Supranational surveillance in the European Union (pages 81–92): Andrea Ammon and Edward van StratenChapter 6 Active, population?based surveillance for infectious diseases (pages 93–108): Chris A. Van Beneden, Melissa Arvay, Somsak Thamthitiwat and Ruth LynfieldChapter 7.1 Surveillance for foodborne diseases: PART 1: Approaches to surveillance for foodborne diseases (pages 109–119): Elaine Scallan, Barbara Mahon and Danilo Lo Fo WongChapter 7.2 Surveillance for foodborne diseases: PART 2: Investigation of foodborne disease outbreaks (pages 120–128): Stephanie D. Meyer, Kirk E. Smith and Craig HedbergChapter 7.3 Surveillance for foodborne diseases: PART 3: Surveillance for antimicrobial resistance among foodborne bacteria—the US approach (pages 129–142): Jean M. Whichard, Kathryn Gay, Heather Tate and Tom M. ChillerChapter 8 Surveillance for zoonotic diseases (pages 143–156): Mira J. Leslie and James J. KazmierczakChapter 9 Surveillance for vector?borne diseases (pages 157–173): Lyle R. Petersen and James L. HadlerChapter 10 Surveillance for vaccine?preventable diseases (pages 174–186): Hanna M. Nohynek and Elizabeth MillerChapter 11 Public health surveillance for vaccine adverse events (pages 187–199): John K. Iskander and Yenlik ZheteyevaChapter 12 Seasonal and pandemic influenza surveillance (pages 200–210): Lynnette Brammer, Alicia P. Budd and Lyn FinelliChapter 13 Surveillance for agents of bioterrorism in the USA (pages 211–222): Richard N. Danila and Aaron T. FleischauerChapter 14 Surveillance for unexplained infectious disease?related deaths (pages 223–233): Ruth Lynfield, Kurt B. Nolte, Ann M. Schmitz and Marc FischerChapter 15 Surveillance for tuberculosis (pages 234–247): Delphine Antoine and Ibrahim AbubakarChapter 16 Surveillance for healthcare?associated infections (pages 248–260): Petra Gastmeier, Bruno Coignard and Teresa C. HoranChapter 17 Biovigilance: designing and implementing surveillance systems for the safety and quality of blood, organs, and tissues (pages 261–273): Matthew J. Kuehnert, Robert P. Wise and Jerry A. HolmbergChapter 18 Surveillance for antimicrobial resistance and trends in antimicrobial utilization (pages 274–287): Katherine Fleming?Dutra, Lauri A. Hicks and Hajo GrundmannChapter 19 Surveillance for viral hepatitis in Europe (pages 288–303): Mary E. Ramsay, Koye Balogun, Catherine Quigley and Chee Fu YungChapter 20 Surveillance for human immunodeficiency virus infection in the USA (pages 304–316): Eve D. Mokotoff and R. Luke ShouseChapter 21.1 Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome for countries in transition: PART 1: Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome in India (pages 317–326): Rubina Imtiaz, Renu Garg and Madhulekha BhattacharyaChapter 21.2 Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome for countries in transition: PART 2: Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome in Russia (pages 327–333): Dmitry M. Kissin, Charles R. Vitek, Evgeny Voronin and Susan D. HillisChapter 21.3 Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome for countries in transition: PART 3: Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome in South Africa (pages 334–342): Thomas M. Rehle and Gita RamjeeChapter 22 Surveillance for sexually transmitted diseases (pages 343–360): Samuel L. Groseclose, Michael C. Samuel, Joan M. Chow and Hillard WeinstockChapter 23 Communicable disease surveillance during complex emergencies (pages 361–375): Marta Valenciano, Francisco J. Luquero and Alain MorenChapter 24 Infectious disease surveillance in globally mobile populations (pages 376–387): Katrin S. Kohl and Alfonso Rodriguez?LainzChapter 25 Surveillance for infectious diseases in mass gatherings (pages 388–399): Andrea M. FordeChapter 26 Use of the Web to enhance infectious disease surveillance (pages 401–417): Nkuchia M. M'ikanatha, Dale D. Rohn, Toby McAdams, David P. Welliver and Kathleen G. JulianChapter 27 Web?based sentinel provider surveillance network in France (pages 418–425): Thierry BlanchonChapter 28 Electronic surveillance for infectious diseases in Germany (pages 426–433): Gerard KrauseChapter 29 Electronic clinical laboratory reporting for public health surveillance (pages 434–446): Perry F. Smith, Guthrie S. Birkhead and J.A. MagnusonChapter 30 Mobile technology for infectious disease surveillance (pages 447–456): Herman D. Tolentino, John S. Brownstein, Barbara L. Massoudi and Mehran S. MassoudiChapter 31 The Global Public Health Intelligence Network (pages 457–469): Abla Mawudeku, Michael Blench, Louise Boily, Ron St. John, Roberta Andraghetti and Martha RubenChapter 32 Syndromic surveillance for infectious diseases (pages 470–481): Julie A. PavlinChapter 33 Use of molecular epidemiology in infectious disease surveillance (pages 483–501): John M. BesserChapter 34.1 Software applications, resources, and introduction to statistical analysis: PART 1: Examples of software application and Web?based resources for infectious disease surveillance (pages 502–507): John H. Holmes, Michael C. Samuel, Gilles Desve and Joseph M. HilbeChapter 34.2 Software applications, resources, and introduction to statistical analysis: PART 2: Analysis and interpretation of reportable infectious disease data (pages 508–521): Mindy J. Perilla and Elizabeth R. ZellChapter 35 Analysis and interpretation of case?based infectious disease surveillance data: human immunodeficiency virus?related morbidity and mortality surveillance in the USA (pages 522–534): Lisa M. Lee and George W. RutherfordChapter 36 Statistical modeling of infectious disease surveillance data (pages 535–544): Leonhard Held and Michaela PaulChapter 37.1 Geospatial technologies and spatial data analysis: PART 1: Geographic information system approaches to data analysis (pages 545–557): Chester G. Moore and Jerome E. FreierChapter 37.2 Geospatial technologies and spatial data analysis: PART 2: Use of geographic information systems and spatial analysis in infectious disease surveillance in North America and East Africa (pages 558–564): Sunny Mak and Rebecca J. EisenChapter 38 Evaluation of syndromic surveillance systems that use healthcare data (pages 565–579): Samuel L. Groseclose, David L. Buckeridge and James W. BuehlerChapter 39 Legal basis for infectious disease surveillance and control in the USA (pages 581–595): Richard E. Hoffman and Frederic E. ShawChapter 40 Ethics and public health surveillance (pages 596–606): Amy L. Fairchild and David M. JohnsChapter 41.1 Communication in infectious disease surveillance: PART 1: Communication, mass media relations, and infectious disease surveillance (pages 607–617): Brian G. Southwell, Barbara J. Reynolds and Kate FowlieChapter 41.2 Communication in infectious disease surveillance: PART 2: Health communication case study (pages 618–622): Jeffrey D. Klausner and Katherine AhrensChapter 42 Training in infectious disease surveillance: contributions of the Epidemic Intelligence Service and European field epidemiology training programs (pages 623–635): Denise Koo, Douglas H. Hamilton and Arnold BosmanChapter 43 Surveillance training for Fogarty international fellows from Eastern Europe and Central Asia: the New York State experience (pages 636–645): Dale L. Morse, Robert A. Bednarczyk and Louise?Anne McNuttChapter 44 Public–private partnerships in infectious disease surveillance (pages 647–656): Andrew FriedeChapter 45 2009 pandemic influenza A (H1N1) surveillance in the USA (pages 657–667): Michael A. Jhung, Lynnette Brammer and Lyn FinelliChapter 46 Future directions in infectious disease surveillance (pages 668–670): Ruth Lynfield, Nkuchia M. M'ikanatha, Chris A. Van Beneden and Henriette de Valk